Revolutionizing type 2 diabetes treatment: personalized approach shows promise in matching patients with optimal glucose-lowering therapies

FHS
August 10, 2023
10:37 am

A personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes.

BIO-Europe 2023: Barriers remain in the AI pharma revolution – Pharmaceutical Technology

Despite rapid growth, several challenges remain when it comes to incorporating artificial intelligence (AI) into biotech operations. Image Credit: Getty Images/ Vertigo3d Despite the shift

November 10, 2023

BioCardia unveils interim data that led it to stop PhIII enrollment of heart failure stem cell therapy

BioCardia disclosed that its heart failure stem cell therapy failed to hit on all three measures that comprised the primary endpoint of a Phase III

September 6, 2023

Rockefeller researchers reveal the mechanisms behind malignant turn of events in cancer

Early on, every stem cell faces a fateful choice. During skin development, for instance, the embryonic epidermis begins as a single layer of epidermal progenitor

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.